Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%

NCT00101673 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: vildagliptin

Sponsor

Novartis Pharmaceuticals